$2.65 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
-Total revenue in the last quarter.
$-20.7 MillionNet income is all revenues minus all expenses including taxes and interest in the last quarter.
$-1.07Earnings per share is the amount of net income that is attributed to each single share outstanding.
-Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
-28.3xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$-20.5 MillionEarnings before interest expenses and taxes in the last quarter.
108The number of full time employees.
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
Seres Therapeutics (NASDAQ:MCRB) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research report issued on Thursday, BidAskClub reports. MCRB has be...Dakota Financial News, 1 day ago
Seres Therapeutics Inc (NASDAQ:MCRB)’s stock price fell 10.8% during trading on Wednesday . The company traded as low as $28.11 and last traded at $28.20. 635,648 shares were traded during mid-day ...The Olympia Report, 4 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq:MCRB) today announced that management will present at two upcoming investor conferences: H.C. Wainwright 22nd Annual Global Inves...Business Wire, about 1 month ago